Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Pfizer (PFE) stock forecast for 2022 and beyond
This page explores the latest Pfizer stock price forecasts from leading investment analysts. We have compiled a selection of PFE price predictions for both the long and short term to help you time your investment into it.
PFE stock forecast & price target
The majority of analysts are of the opinion that holding Pfizer shares is the best option. Most expect its price to rise, although how much upside potential it has is up for debate. The highest PFE stock price forecast comes in at $76, while the lowest is $49. Below we’ve summarised the latest Pfizer stock price predictions and provided an average.
| Stock | Average price target | Highest target | Lowest target | Majority guidance |
|---|---|---|---|---|
| Pfizer (PFE) | $55 | $76 | $49 | HOLD |
Expert forecasts on the future of Pfizer (PFE)
Below you will find a selection of quotes from the most prominent expert opinions on the future of the stock, helping you gain an insight into what the analysts think.
Our views on Pfizer come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic and we feel the trajectory for both remains highly uncertain.
Chris Shibutani, Goldman Sachs, $51 price target
With an implied core multiple already well above peers facing mid- to late-decade patent expirations , we see PFE shares as fully valued at current levels and believe it is unlikely vaccine upside alone can drive shares meaningfully above current levels”
Chris Schott. JP Morgan, $57 price target
Short term PFE forecast
In the short term the general consensus is that Pfizer’s stock price may see little movement. The pandemic and subsequent vaccine helped push the company’s share price much higher and analysts believe it will likely stay flat. Below are expert PFE stock price forecasts for the next two years.
Pfizer stock price prediction 2022
Pfizer’s stock price may climb to $55 in 2022. That figure is the average forecasted price from the 19 analysts who have given price targets. $55 is just short of where its price opened in 2022 at $58.50.
Pfizer stock price prediction 2023
In 2023 Pfizer’s stock price could reach $60.65. That target has been reached using the same average growth forecast from the previous year. If it does get there, it will be just shy of its all-time high set in late 2021 at $61.71.
Long term PFE forecast
Most experts tend not to provide long term forecasts, however for large companies like Pfizer, some have. Below is a summary of Pfizer stock price forecasts for the remainder of the decade. It’s important to note that longer term predictions are more speculative in nature.
Pfizer price prediction 2024
PFE’s stock price could be trading at $70 in 2024. That price is inline with analysts at Bank of America who in January 2022 upgraded their rating from neutral to buy for the company.
Pfizer price prediction 2025
In 2025 Pfizer’s stock price is forecast to be between $70 – $90. The most bullish price forecast is $76 from BMO Capital Markets, although other analysts expect strong momentum from the company within the next several years.
Pfizer price prediction 2030
Some experts have suggested that Pfizer’s stock could break above $100 by the end of the decade. However, a lot needs to fall into place between now and then for its stock price to hit triple digits.
Compare the best places to buy Pfizer stock
If you agree with the experts and want to buy some Pfizer stock you’ll need to use an online broker to do so. Check out the table below which includes a list of the best brokers around for buying PFE stock. Click on any of the links to get started in just a few minutes.
What affects the price of PFE?
Pfizer is one of the largest pharmaceutical companies in the world so it’s little surprise that medicines and vaccines are key drivers in its performance. There are a range of different factors that impact its stock price and below we’ve briefly explained a few of the top ones.
- Medicines and vaccines. During the pandemic Pfizer became somewhat of a household name when it delivered a covid19 vaccine. However, it’s not just vaccines it develops and medicines are a large part of its revenue. Its ability to create new medicines will be reflected in its share price.
- Covid. In 2021 Pfizer made $37 billion from its Covid vaccine. Thanks to the jab, its revenue doubled to over $80 billion from 2020. It’s in the process of developing a Covid pill which it expects will add to sales. Any new Covid variants will likely be positive for the company, who are one of the world’s few covid19 vaccine suppliers.
- Competition. The pharmaceutical industry is massive and has lots of key players operating within it. Pfizer has stiff competition from the likes of Roche, Eli Lilly, Abbvie, and Novartis. These companies develop similar drugs to that of Pfizer and the race to cure illnesses like cancer between the businesses is ongoing.
How has the Pfizer price changed over time?
It’s been a strong performer for the past decade or so. Since 2009 its stock price has been on a steady incline and has increased by over 400%. Unsurprisingly, the past couple of years have been extremely good for the company. Following its development and release of its Covid19 vaccine, shares in the company have more than doubled.
What should I do now?
Now that you have some expert opinions and forecasts on Pfizer stock you may want to consider buying shares in the company. To do so you’ll need to register with an online brokerage firm. Alternatively to learn more about the stock market you can check out our hub page with free courses. Whatever you decide, it’s a good idea to keep up to date with the latest news and market analysis, which you can do so by the links below.
Latest Pfizer news
This biotech stock is up 100% on Tuesday: here’s the catalyst
Here is why Biohaven Pharmaceuticals soared 70%
Pfizer lowers earnings guidance despite a solid Q1
Fact-checking & references
Our editors fact-check all content to ensure compliance with our strict editorial policy. The information in this article is supported by the following reliable sources.
Invezz is a place where people can find reliable, unbiased information about finance, trading, and investing – but we do not offer financial advice and users should always carry out their own research. The assets covered on this website, including stocks, cryptocurrencies, and commodities can be highly volatile and new investors often lose money. Success in the financial markets is not guaranteed, and users should never invest more than they can afford to lose. You should consider your own personal circumstances and take the time to explore all your options before making any investment. Read our risk disclaimer >